Hos patienter, der har klasse III- symptomer, har 10 mg Volibris vist sig at have ekstra effekt, selvom der også er observeret en stigning i forekomsten af perifere ødemer.
Some additional efficacy has been observed with 10 mg Volibris in patients with class III symptoms, however an increase in peripheral oedema has also been observed.